These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 16651889
1. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A. J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889 [Abstract] [Full Text] [Related]
2. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, Mizuno Y, Mochizuki H. Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295 [Abstract] [Full Text] [Related]
3. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K. Neurosci Lett; 2010 Dec 03; 486(1):19-23. PubMed ID: 20851165 [Abstract] [Full Text] [Related]
4. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease. Gómez-Tortosa E, Gonzalo I, Fanjul S, Sainz MJ, Cantarero S, Cemillán C, Yébenes JG, del Ser T. Arch Neurol; 2003 Sep 03; 60(9):1218-22. PubMed ID: 12975286 [Abstract] [Full Text] [Related]
5. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases. Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Nakashima H, Yasuda M, Kitamura Y, Uéda K, Checler F, Kuroda S. Acta Neuropathol; 2002 Dec 03; 104(6):637-48. PubMed ID: 12410385 [Abstract] [Full Text] [Related]
6. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies. Campbell BC, Li QX, Culvenor JG, Jäkälä P, Cappai R, Beyreuther K, Masters CL, McLean CA. Neurobiol Dis; 2000 Jun 03; 7(3):192-200. PubMed ID: 10860784 [Abstract] [Full Text] [Related]
7. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease. Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, El-Agnaf OM, Yamada M. Brain Res; 2009 Jan 28; 1251():1-6. PubMed ID: 19071095 [Abstract] [Full Text] [Related]
8. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Jellinger KA, Attems J. Acta Neuropathol; 2006 Sep 28; 112(3):253-60. PubMed ID: 16804711 [Abstract] [Full Text] [Related]
10. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology. Tsuboi Y, Uchikado H, Dickson DW. Parkinsonism Relat Disord; 2007 Sep 28; 13 Suppl 3():S221-4. PubMed ID: 18267239 [Abstract] [Full Text] [Related]
11. Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies. Beyer K, Lao JI, Carrato C, Mate JL, López D, Ferrer I, Ariza A. Brain Res Mol Brain Res; 2004 Nov 24; 131(1-2):131-5. PubMed ID: 15530662 [Abstract] [Full Text] [Related]
12. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Beyer MK, Larsen JP, Aarsland D. Neurology; 2007 Aug 21; 69(8):747-54. PubMed ID: 17709706 [Abstract] [Full Text] [Related]
13. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Jellinger KA, Attems J. Acta Neuropathol; 2008 Apr 21; 115(4):427-36. PubMed ID: 18273624 [Abstract] [Full Text] [Related]
14. CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease. Mollenhauer B, Esselmann H, Trenkwalder C, Schulz-Schaeffer W, Kretzschmar H, Otto M, Wiltfang J, Bibl M. J Alzheimers Dis; 2011 Apr 21; 24(2):383-91. PubMed ID: 21297274 [Abstract] [Full Text] [Related]
15. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro. Ono K, Noguchi-Shinohara M, Yoshita M, Naiki H, Yamada M. Exp Neurol; 2007 Feb 21; 203(2):579-83. PubMed ID: 17011551 [Abstract] [Full Text] [Related]
16. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology. Newman J, Rissman RA, Sarsoza F, Kim RC, Dick M, Bennett DA, Cotman CW, Rohn TT, Head E. Acta Neuropathol; 2005 Aug 21; 110(2):135-44. PubMed ID: 15986225 [Abstract] [Full Text] [Related]
17. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases. Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Namba M, Hayashi Y, Nishinaka T, Namba R, Nakashima H, Uéda K, Checler F, Kuroda S. Acta Neuropathol; 2003 Oct 21; 106(4):348-56. PubMed ID: 12883830 [Abstract] [Full Text] [Related]
18. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies. Beyer K, Lao JI, Carrato C, Mate JL, López D, Ferrer I, Ariza A. Neuropathol Appl Neurobiol; 2004 Dec 21; 30(6):601-7. PubMed ID: 15541000 [Abstract] [Full Text] [Related]
20. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor. Barrachina M, Dalfó E, Puig B, Vidal N, Freixes M, Castaño E, Ferrer I. Neurochem Int; 2005 Feb 21; 46(3):253-60. PubMed ID: 15670642 [Abstract] [Full Text] [Related] Page: [Next] [New Search]